Efficacy News and Research

RSS
Scientists outline how organ rejuvenation strategies could solve the donor shortage

Scientists outline how organ rejuvenation strategies could solve the donor shortage

How specific foods reshape oxidative stress responses during and after high-intensity training

How specific foods reshape oxidative stress responses during and after high-intensity training

Study finds dramatic increase in ADHD medication use

Study finds dramatic increase in ADHD medication use

Cleveland Clinic reports promising results for breast cancer vaccine from final Phase 1 data

Cleveland Clinic reports promising results for breast cancer vaccine from final Phase 1 data

Blocking collagen signaling improves the delivery of macromolecular drugs in pancreatic cancer

Blocking collagen signaling improves the delivery of macromolecular drugs in pancreatic cancer

Study finds sharp rise in prescriptions for stimulant medications used to treat ADHD

Study finds sharp rise in prescriptions for stimulant medications used to treat ADHD

Wheelchair? Hearing aids? Yes. ‘Disabled?' No way.

Wheelchair? Hearing aids? Yes. ‘Disabled?' No way.

Mathematical modeling identifies strategies to eliminate cervical cancer

Mathematical modeling identifies strategies to eliminate cervical cancer

Why the form of vitamin B12 you take may matter more than your intake

Why the form of vitamin B12 you take may matter more than your intake

Van Andel Institute and Cure Parkinson's extend major Parkinson's drug trial initiative

Van Andel Institute and Cure Parkinson's extend major Parkinson's drug trial initiative

Addition of tucatinib to the standard of care delays disease progression in HER2-positive metastatic breast cancer

Addition of tucatinib to the standard of care delays disease progression in HER2-positive metastatic breast cancer

Triaptosis could be a promising strategy in the fight against cancer

Triaptosis could be a promising strategy in the fight against cancer

EpilepsyGTx raises $33 million Series A to develop single dose gene therapy for focal refractory epilepsy

EpilepsyGTx raises $33 million Series A to develop single dose gene therapy for focal refractory epilepsy

Tec-Dara could represent a new standard of care for relapsed or refractory multiple myeloma

Tec-Dara could represent a new standard of care for relapsed or refractory multiple myeloma

Pirtobrutinib shows superior outcomes compared to common first-line combination treatment for CLL/SLL

Pirtobrutinib shows superior outcomes compared to common first-line combination treatment for CLL/SLL

Sterilized fermented beverage targets obesity and type 2 diabetes pathways in computational study

Sterilized fermented beverage targets obesity and type 2 diabetes pathways in computational study

SwRI and Trinity researchers work on next-generation intranasal therapy for PTSD

SwRI and Trinity researchers work on next-generation intranasal therapy for PTSD

Laughing gas shows fast antidepressant effects in early clinical trials

Laughing gas shows fast antidepressant effects in early clinical trials

Combination therapy may boost survival for people with aggressive lymphoma

Combination therapy may boost survival for people with aggressive lymphoma

Lubiprostone shows signs of slowing kidney function decline in chronic kidney disease

Lubiprostone shows signs of slowing kidney function decline in chronic kidney disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.